1.000000
0.000000
0.000000
0.000000
1.000000
0.000000
0.000000
0.000000
1.000000
0.00000
0.00000
0.00000
Hua, Y.
Kuhlman, B.
Hoffman, D.
Raleigh, D.P.
http://mmcif.pdb.org/dictionaries/ascii/mmcif_pdbx.dic
1
90.0
90.0
90.0
1.0
1.0
1.0
C3 H7 N O2
89.093
y
ALANINE
L-peptide linking
C6 H15 N4 O2 1
175.209
y
ARGININE
L-peptide linking
C4 H8 N2 O3
132.118
y
ASPARAGINE
L-peptide linking
C4 H7 N O4
133.103
y
ASPARTIC ACID
L-peptide linking
C5 H10 N2 O3
146.144
y
GLUTAMINE
L-peptide linking
C5 H9 N O4
147.129
y
GLUTAMIC ACID
L-peptide linking
C2 H5 N O2
75.067
y
GLYCINE
peptide linking
C6 H13 N O2
131.173
y
ISOLEUCINE
L-peptide linking
C6 H13 N O2
131.173
y
LEUCINE
L-peptide linking
C6 H15 N2 O2 1
147.195
y
LYSINE
L-peptide linking
C5 H11 N O2 S
149.211
y
METHIONINE
L-peptide linking
C9 H11 N O2
165.189
y
PHENYLALANINE
L-peptide linking
C5 H9 N O2
115.130
y
PROLINE
L-peptide linking
C4 H9 N O3
119.119
y
THREONINE
L-peptide linking
C9 H11 N O3
181.189
y
TYROSINE
L-peptide linking
C5 H11 N O2
117.146
y
VALINE
L-peptide linking
UK
J.Mol.Biol.
JMOBAK
0070
0022-2836
289
167
174
10.1006/jmbi.1999.2742
10339414
Effects of varying the local propensity to form secondary structure on the stability and folding kinetics of a rapid folding mixed alpha/beta protein: characterization of a truncation mutant of the N-terminal domain of the ribosomal protein L9.
1999
IX
Eur.J.Biochem.
EJBCAI
0262
0014-2956
13
205
Crystal Structure of Prokaryotic Ribosomal Protein L9: A Bi-Lobed RNA-Binding
Protein
1994
10.2210/pdb1cqu/pdb
pdb_00001cqu
1.000000
0.000000
0.000000
0.000000
1.000000
0.000000
0.000000
0.000000
1.000000
0.00000
0.00000
0.00000
6231.309
50S RIBOSOMAL PROTEIN L9
N-TERMINAL DOMAIN
1
nat
polymer
no
no
MKVIFLKDVKGKGKKGEIKNVADGYANNFLFKQGLAIEATPANLKALEAQKQKEQR
MKVIFLKDVKGKGKKGEIKNVADGYANNFLFKQGLAIEATPANLKALEAQKQKEQR
A
polypeptide(L)
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
Geobacillus
sample
1422
Geobacillus stearothermophilus
database_2
pdbx_struct_assembly
pdbx_struct_oper_list
repository
Initial release
Version format compliance
Version format compliance
Database references
Derived calculations
1
0
2002-04-27
1
1
2008-04-27
1
2
2011-07-13
1
3
2022-02-16
_database_2.pdbx_DOI
_database_2.pdbx_database_accession
RCSB
Y
RCSB
1999-08-11
REL
REL
structures with the least restraint violations
50
18
2D NOESY
5.0
AMBIENT
298
K
DISTANCE GEOMETRY SIMULATED ANNEALING
BRUNGER
structure calculation
X-PLOR
3.81
BRUNGER
refinement
X-PLOR
3.81
600
Varian
INOVA
MET
1
n
1
MET
1
A
LYS
2
n
2
LYS
2
A
VAL
3
n
3
VAL
3
A
ILE
4
n
4
ILE
4
A
PHE
5
n
5
PHE
5
A
LEU
6
n
6
LEU
6
A
LYS
7
n
7
LYS
7
A
ASP
8
n
8
ASP
8
A
VAL
9
n
9
VAL
9
A
LYS
10
n
10
LYS
10
A
GLY
11
n
11
GLY
11
A
LYS
12
n
12
LYS
12
A
GLY
13
n
13
GLY
13
A
LYS
14
n
14
LYS
14
A
LYS
15
n
15
LYS
15
A
GLY
16
n
16
GLY
16
A
GLU
17
n
17
GLU
17
A
ILE
18
n
18
ILE
18
A
LYS
19
n
19
LYS
19
A
ASN
20
n
20
ASN
20
A
VAL
21
n
21
VAL
21
A
ALA
22
n
22
ALA
22
A
ASP
23
n
23
ASP
23
A
GLY
24
n
24
GLY
24
A
TYR
25
n
25
TYR
25
A
ALA
26
n
26
ALA
26
A
ASN
27
n
27
ASN
27
A
ASN
28
n
28
ASN
28
A
PHE
29
n
29
PHE
29
A
LEU
30
n
30
LEU
30
A
PHE
31
n
31
PHE
31
A
LYS
32
n
32
LYS
32
A
GLN
33
n
33
GLN
33
A
GLY
34
n
34
GLY
34
A
LEU
35
n
35
LEU
35
A
ALA
36
n
36
ALA
36
A
ILE
37
n
37
ILE
37
A
GLU
38
n
38
GLU
38
A
ALA
39
n
39
ALA
39
A
THR
40
n
40
THR
40
A
PRO
41
n
41
PRO
41
A
ALA
42
n
42
ALA
42
A
ASN
43
n
43
ASN
43
A
LEU
44
n
44
LEU
44
A
LYS
45
n
45
LYS
45
A
ALA
46
n
46
ALA
46
A
LEU
47
n
47
LEU
47
A
GLU
48
n
48
GLU
48
A
ALA
49
n
49
ALA
49
A
GLN
50
n
50
GLN
50
A
LYS
51
n
51
LYS
51
A
GLN
52
n
52
GLN
52
A
LYS
53
n
53
LYS
53
A
GLU
54
n
54
GLU
54
A
GLN
55
n
55
GLN
55
A
ARG
56
n
56
ARG
56
A
author_defined_assembly
1
monomeric
1.0000000000
0.0000000000
0.0000000000
0.0000000000
1.0000000000
0.0000000000
0.0000000000
0.0000000000
1.0000000000
1_555
x,y,z
identity operation
0.0000000000
0.0000000000
0.0000000000
A
N
LYS
19
A
N
LYS
19
A
O
VAL
3
A
O
VAL
3
A
N
ILE
4
A
N
ILE
4
A
O
ILE
37
A
O
ILE
37
1
A
A
H2
OD1
MET
ASP
1
23
1.50
1
A
A
O
H
ALA
GLN
46
50
1.57
2
A
A
O
H
TYR
ASN
25
28
1.45
3
A
A
O
H
TYR
ASN
25
28
1.50
4
A
A
O
H
TYR
ASN
25
28
1.48
4
A
A
H
O
VAL
GLY
9
13
1.53
5
A
A
O
H
VAL
GLY
9
11
1.46
5
A
A
O
H
TYR
ASN
25
28
1.46
7
A
A
O
H
TYR
ASN
25
28
1.56
9
A
A
O
H
TYR
ASN
25
28
1.57
10
A
A
O
H
TYR
ASN
25
28
1.44
12
A
A
O
H
ALA
GLN
46
50
1.47
12
A
A
O
H
TYR
ASN
25
28
1.57
13
A
A
O
H
TYR
ASN
25
28
1.58
14
A
A
O
H
ALA
GLN
46
50
1.50
14
A
A
O
H
GLU
THR
38
40
1.53
14
A
A
O
H
VAL
GLY
9
11
1.59
15
A
A
HZ2
OD1
LYS
ASN
19
20
1.46
16
A
A
HA
H
VAL
GLY
9
13
1.34
16
A
A
O
H
TYR
ASN
25
28
1.42
16
A
A
O
H
VAL
GLY
9
11
1.56
16
A
A
O
O
LYS
GLY
7
13
2.14
16
A
A
C
O
ASP
GLY
8
13
2.17
17
A
A
O
H
TYR
ASN
25
28
1.55
18
A
A
O
H
GLU
LYS
48
51
1.58
1
A
ARG
56
0.308
SIDE CHAIN
2
A
ARG
56
0.299
SIDE CHAIN
3
A
ARG
56
0.277
SIDE CHAIN
4
A
ARG
56
0.115
SIDE CHAIN
6
A
ARG
56
0.306
SIDE CHAIN
7
A
ARG
56
0.277
SIDE CHAIN
8
A
ARG
56
0.249
SIDE CHAIN
9
A
ARG
56
0.111
SIDE CHAIN
10
A
ARG
56
0.236
SIDE CHAIN
11
A
ARG
56
0.303
SIDE CHAIN
12
A
ARG
56
0.127
SIDE CHAIN
13
A
ARG
56
0.172
SIDE CHAIN
14
A
ARG
56
0.218
SIDE CHAIN
15
A
ARG
56
0.317
SIDE CHAIN
16
A
ARG
56
0.187
SIDE CHAIN
17
A
ARG
56
0.318
SIDE CHAIN
18
A
ARG
56
0.079
SIDE CHAIN
5
-13.75
2.10
128.40
114.65
A
A
A
C
N
CD
THR
PRO
PRO
40
41
41
Y
1
A
LYS
2
-49.66
151.25
1
A
VAL
9
-123.24
-142.15
1
A
LYS
15
-32.85
137.28
1
A
VAL
21
-86.94
-143.39
1
A
ASP
23
-31.61
-31.16
1
A
ALA
26
-29.78
-61.52
1
A
PHE
29
-160.96
-52.68
1
A
GLN
33
-133.22
-93.20
1
A
GLU
38
-56.17
108.73
1
A
LYS
53
-131.66
-100.58
2
A
LYS
2
-49.23
152.12
2
A
VAL
9
-97.32
-155.42
2
A
LYS
19
-161.83
-125.88
2
A
VAL
21
-86.78
-147.01
2
A
ASP
23
-31.36
-31.63
2
A
PHE
29
-161.32
-47.07
2
A
GLN
33
-107.94
-100.87
2
A
ALA
39
-54.39
95.33
2
A
GLU
54
-145.23
-83.80
2
A
GLN
55
-159.98
24.84
3
A
LYS
2
-49.45
156.70
3
A
VAL
9
-116.12
-146.45
3
A
LYS
12
-120.30
-70.67
3
A
LYS
19
-161.68
-124.27
3
A
VAL
21
-86.36
-140.64
3
A
ASP
23
-29.46
-34.22
3
A
ALA
26
-28.75
-58.26
3
A
PHE
29
-151.61
-46.86
3
A
GLU
38
-51.04
108.83
3
A
ALA
39
-49.33
100.22
3
A
GLN
52
-48.32
104.19
3
A
LYS
53
-85.80
41.10
4
A
LYS
12
-137.74
-41.69
4
A
LYS
19
-161.17
-127.53
4
A
VAL
21
-87.48
-146.57
4
A
ASP
23
-30.65
-32.28
4
A
ALA
26
-29.39
-60.23
4
A
PHE
29
-160.65
-52.83
4
A
GLU
38
-38.65
113.83
4
A
ALA
39
-48.58
99.24
4
A
GLN
52
-73.01
-78.30
4
A
LYS
53
-58.16
89.84
5
A
LYS
7
-95.72
-152.52
5
A
LYS
10
-64.72
70.12
5
A
LYS
12
-151.15
-87.06
5
A
LYS
15
-28.70
121.32
5
A
LYS
19
-161.54
-127.87
5
A
VAL
21
-87.55
-149.29
5
A
ASP
23
-30.59
-31.53
5
A
PHE
29
-160.56
-52.88
5
A
LYS
32
-69.95
0.28
5
A
GLU
38
-55.11
105.06
5
A
ALA
39
-54.17
89.79
5
A
ALA
42
-36.10
-35.13
5
A
LYS
53
-53.45
-72.36
6
A
VAL
9
-130.92
-157.81
6
A
LYS
15
-37.95
134.43
6
A
LYS
19
-160.97
-126.37
6
A
VAL
21
-87.23
-143.89
6
A
ASP
23
-31.42
-30.52
6
A
ALA
26
-28.69
-60.60
6
A
ASN
27
-89.30
34.03
6
A
PHE
29
-160.69
-46.42
6
A
GLN
33
-127.97
-114.31
6
A
GLU
38
-37.05
108.94
6
A
ALA
39
-55.97
97.85
6
A
GLN
55
-137.28
-31.36
7
A
LYS
7
-118.65
-163.75
7
A
VAL
9
-124.89
-162.74
7
A
LYS
10
-65.74
83.05
7
A
LYS
12
-108.54
-67.61
7
A
VAL
21
-87.14
-144.56
7
A
ASP
23
-31.51
-31.20
7
A
PHE
29
-161.17
-46.78
7
A
GLN
33
-114.57
-92.89
7
A
ALA
39
-59.21
83.85
7
A
ALA
42
-36.52
-30.15
7
A
ASN
43
-93.71
-60.65
7
A
GLN
55
-147.83
-41.04
8
A
LYS
10
-56.24
82.93
8
A
LYS
12
-142.99
-61.44
8
A
VAL
21
-87.25
-150.20
8
A
ASP
23
-30.86
-32.24
8
A
ALA
26
-29.25
-57.41
8
A
PHE
29
-160.31
-99.58
8
A
LEU
30
-29.81
-42.48
8
A
ALA
39
-54.40
99.91
8
A
GLN
52
-53.40
-174.35
8
A
GLN
55
-159.96
22.84
9
A
LYS
7
-117.76
-165.75
9
A
VAL
9
-99.66
-154.98
9
A
LYS
12
-126.45
-67.80
9
A
LYS
19
-160.99
-127.09
9
A
VAL
21
-87.02
-141.37
9
A
ASP
23
-31.16
-32.31
9
A
ALA
26
-29.44
-64.08
9
A
ASN
27
-89.75
33.54
9
A
PHE
29
-160.73
-49.48
9
A
GLN
33
-123.90
-111.16
9
A
ALA
39
-51.31
97.17
9
A
GLU
54
-145.48
-51.01
9
A
GLN
55
-160.15
48.89
10
A
VAL
9
-125.72
-143.96
10
A
LYS
12
-146.06
-75.71
10
A
LYS
19
-161.00
-128.96
10
A
VAL
21
-87.51
-146.53
10
A
ASP
23
-32.24
-29.88
10
A
ALA
26
-29.39
-60.39
10
A
PHE
29
-161.24
-58.59
10
A
GLU
38
-59.66
107.17
10
A
ALA
39
-63.64
96.88
10
A
LEU
47
-38.84
-27.73
10
A
GLU
54
-158.80
-80.56
11
A
LYS
7
-115.31
-163.39
11
A
VAL
9
-121.18
-158.74
11
A
VAL
21
-87.54
-144.49
11
A
ASP
23
-33.57
-30.54
11
A
ALA
26
-29.01
-59.21
11
A
PHE
29
-160.71
-77.51
11
A
ALA
39
-49.53
107.07
11
A
GLN
52
-66.33
-149.43
11
A
LYS
53
-57.93
-171.08
11
A
GLN
55
-155.97
27.56
12
A
LYS
7
-115.81
-166.16
12
A
LYS
12
-151.55
-25.55
12
A
LYS
19
-161.79
-121.87
12
A
VAL
21
-86.78
-144.79
12
A
ASP
23
-30.38
-33.06
12
A
PHE
29
-161.01
-43.90
12
A
GLN
33
-113.89
-105.70
12
A
GLU
38
-38.85
116.96
12
A
LYS
53
-157.03
71.67
12
A
GLN
55
-140.64
19.37
13
A
VAL
9
-106.96
-157.77
13
A
LYS
10
-61.73
76.33
13
A
LYS
12
-131.65
-83.73
13
A
LYS
19
-161.54
-125.72
13
A
VAL
21
-87.33
-142.32
13
A
ASP
23
-31.66
-31.46
13
A
PHE
29
-161.33
-50.85
13
A
GLN
33
-114.33
-88.60
13
A
GLU
38
-39.49
115.04
13
A
ALA
39
-48.34
102.21
13
A
LYS
53
-99.74
-131.34
13
A
GLN
55
-157.74
73.16
14
A
LYS
10
-67.13
62.81
14
A
LYS
19
-160.79
-127.82
14
A
VAL
21
-86.89
-142.66
14
A
ASP
23
-29.67
-37.30
14
A
ALA
26
-29.97
-63.94
14
A
ASN
27
-88.68
35.31
14
A
PHE
29
-160.74
-47.24
14
A
GLN
33
-116.72
-92.13
14
A
ALA
39
-66.99
60.64
14
A
GLN
52
-61.98
-170.69
14
A
GLN
55
-150.64
44.06
15
A
LYS
7
-121.97
-164.58
15
A
LYS
10
-54.09
85.32
15
A
LYS
12
-146.72
-32.83
15
A
LYS
19
-161.40
-130.93
15
A
VAL
21
-86.88
-144.06
15
A
ASP
23
-32.05
-30.33
15
A
ALA
26
-29.57
-64.48
15
A
ASN
28
-157.94
-32.35
15
A
GLN
33
-118.84
-102.22
15
A
GLU
38
-51.06
108.88
15
A
ALA
39
-49.94
96.07
15
A
GLN
55
-149.26
-41.39
16
A
LYS
7
-108.98
-142.86
16
A
LYS
12
-151.03
-18.97
16
A
LYS
15
-29.81
122.03
16
A
LYS
19
-160.96
-129.94
16
A
VAL
21
-87.07
-142.85
16
A
ASP
23
-32.72
-30.13
16
A
ALA
26
-28.75
-58.49
16
A
PHE
29
-159.93
-53.00
16
A
GLN
33
-106.39
-90.06
16
A
ALA
39
-51.76
96.09
16
A
LEU
44
-39.20
-37.77
16
A
GLN
52
-66.91
95.88
16
A
GLN
55
-152.08
35.37
17
A
LYS
15
-34.33
135.06
17
A
LYS
19
-159.89
-130.28
17
A
VAL
21
-86.62
-145.73
17
A
ASP
23
-30.80
-30.48
17
A
ALA
26
-29.89
-63.57
17
A
PHE
29
-135.68
-43.09
17
A
GLN
33
-124.61
-103.08
17
A
GLU
38
-58.28
107.97
17
A
ALA
39
-59.25
93.18
17
A
GLU
54
-93.11
-107.00
17
A
GLN
55
-151.05
19.46
18
A
LYS
12
-135.35
-55.16
18
A
LYS
19
-161.22
-129.98
18
A
VAL
21
-87.34
-146.80
18
A
ASP
23
-29.34
-36.68
18
A
ALA
26
-29.46
-64.34
18
A
ASN
28
-154.89
-31.32
18
A
PHE
29
-130.69
-42.81
18
A
GLN
33
-120.02
-93.78
18
A
ALA
39
-57.20
82.79
18
A
LYS
53
-102.59
-159.97
18
A
GLU
54
-59.58
-70.58
18
A
GLN
55
-144.32
41.52
SOLUTION STRUCTURE OF THE N-TERMINAL DOMAIN OF RIBOSOMAL PROTEIN L9
1
N
N
A
GLY
24
A
GLY
24
HELX_P
A
PHE
29
A
PHE
29
1
1
6
A
THR
40
A
THR
40
HELX_P
A
GLN
50
A
GLN
50
1
2
11
RIBOSOME
PROTEIN L9, RIBOSOME
RL9_BACST
UNP
1
P02417
1
56
1CQU
1
56
P02417
A
1
1
56
3
anti-parallel
anti-parallel
A
GLU
17
A
GLU
17
A
ASN
20
A
ASN
20
A
LYS
2
A
LYS
2
A
PHE
5
A
PHE
5
A
ALA
36
A
ALA
36
A
GLU
38
A
GLU
38
1
P 1